BIO-key International Inc. (NASDAQ:BKYI) Short Interest Update

BIO-key International Inc. (NASDAQ:BKYI) saw a significant decrease in short interest during the month of December. As of December 15th, there was short interest totaling 138,814 shares, a decrease of 64.6% from the November 30th total of 391,579 shares. Based on an average daily trading volume, of 314,389 shares, the days-to-cover ratio is presently 0.4 days. Currently, 1.3% of the company’s shares are sold short. Currently, 1.3% of the company’s shares are sold short. Based on an average daily trading volume, of 314,389 shares, the days-to-cover ratio is presently 0.4 days.

Analyst Ratings Changes

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of BIO-key International in a report on Wednesday, October 8th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company has an average rating of “Sell”.

BIO-key International Stock Down 2.0%

BIO-key International stock traded down $0.01 during trading on Friday, reaching $0.61. 216,270 shares of the company’s stock were exchanged, compared to its average volume of 255,649. The company’s 50-day moving average is $0.78 and its two-hundred day moving average is $0.78. The firm has a market cap of $6.56 million, a price-to-earnings ratio of -0.58 and a beta of 0.35. BIO-key International has a 52-week low of $0.59 and a 52-week high of $3.68. The company has a debt-to-equity ratio of 0.17, a quick ratio of 1.13 and a current ratio of 1.26.

BIO-key International (NASDAQ:BKYI) last posted its quarterly earnings data on Friday, November 14th. The technology company reported ($0.15) EPS for the quarter, missing analysts’ consensus estimates of ($0.12) by ($0.03). BIO-key International had a negative net margin of 70.23% and a negative return on equity of 73.33%. The company had revenue of $1.55 million for the quarter, compared to the consensus estimate of $1.80 million.

About BIO-key International

BIO-key International, Inc is a developer and provider of fingerprint biometric identity and access management solutions, serving enterprise and government customers. The company’s core offerings include a range of fingerprint readers and authentication software designed to verify user identity across physical and digital environments. By leveraging proprietary template-on-card and template-on-device technologies, BIO-key seeks to enhance security and streamline user access without reliance on traditional passwords.

In addition to hardware sensors, BIO-key delivers software platforms that integrate with existing IT infrastructures such as Microsoft Active Directory and major workforce management systems.